IRCT2016100230082N1已完成未知
Effectiveness of Tetrahydrobiopterin for improvement of dietary regimen of children with Phenylketonuria
Mashhad University of Medical Sciences, Vice Chancellor for Research0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 year 至 10 years（—）
- 性别
- All
入选标准
- •patients with controlled PKU; age range of 1-10 years; lack of underlying disorders (e.g. malnutrition, hepatic and renal diseases).
- •Exclusion criteria: BH4 deficiency; Phe levels less than 600 micromoles/liter or more than 1200 micromoles/liter; presence of fever or acute illness; intolerance to BH4 therapy.
排除标准
- 未提供
研究者
相似试验
终止
1 期
Response to Phenylketonuria to Tetrahydrobiopterin (BH4)PhenylketonuriaNCT00244218The University of Texas Medical Branch, Galveston57
已完成
2 期
Study of BH4, a New and Simple Treatment of Mild PKUPhenylketonuriaNCT00260000The Kennedy Institute-National Eye Clinic15
进行中（未招募）
不适用
Effects of tetrahydrobiopterin (6R-BH4) on flow-mediated dilation in CADASIL patients: a randomised controlled trial - CADASIL BH4EUCTR2007-004370-55-ITAZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE)
终止
2 期
Phenylketonuria, Oxidative Stress, and BH4PhenylketonuriaNCT01395394Emory University12
招募中
3 期
The effectiveness of Tiotropium bromide in patients with severe asthmaIRCT20181015041353N1Zahedan University of Medical Sciences60